Assess the structural fragmentation of global health systems across national boundaries, evaluate the costs of non-coordination in pandemic response and disease surveillance, and quantify the efficiency gains available through systems integration.

Analysis of COVID-19 response coordination failures using case studies from 15 countries. WHO disease surveillance integration assessment across 195 member states. Cross-referenced with modeling studies on epidemic control with vs. without international coordination. Economic cost analysis from IMF, World Bank, and disease-specific costing studies.

COVID-19 exposed the catastrophic costs of health system fragmentation: coordinated action to halt flights from pandemic epicenters could have saved 6-9 months of global spread; coordinated vaccine procurement could have reduced inequitable distribution; coordinated data sharing on variants could have enabled earlier detection of Omicron.

The immediate economic cost of uncoordinated pandemic response: $10-15 trillion globally. Yet national health systems remain locked in non-cooperative equilibrium: each country optimizes for its own population without accounting for spillover effects. Only 62 of 195 countries have functional disease surveillance linked to WHO platforms.

Cross-border data sharing on antimicrobial resistance, mpox, and other emerging threats remains fragmented. The pandemic demonstrated that in an era of international disease threat, isolationist health policy is economically irrational.